| Sarmad Sabour, MD | |
|
6870 W 52nd Ave Ste 207, Arvada, CO 80002-3953 | |
| (303) 487-0834 | |
| Not Available |
| Full Name | Sarmad Sabour |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 14 Years |
| Location | 6870 W 52nd Ave Ste 207, Arvada, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902007743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 48611 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mile High Otolaryngology | 9931000601 | 3 |
News Archive
A monumental discovery that provides the promise of a cure not only for leukaemia, but cancer at large was announced this morning in London during GIL 2012: Europe. Steve Shor, the founder of the National Children's Leukemia Foundation, a leading non-profit organisation in the United States, unveiled a ground-breaking therapy his research teams in the United States and Israel have discovered.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in their extensive environmental monitoring (EM) programme for over 20 years
Edmonton researchers recommend that people over age 40 be screened for peripheral artery disease (PAD), which puts people at high risk for serious medical complications including heart disease, stroke, and possible lower limb amputation.
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
› Verified 7 days ago
| Entity Name | Mile High Otolaryngology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699854463 PECOS PAC ID: 9931000601 Enrollment ID: O20040115000955 |
News Archive
A monumental discovery that provides the promise of a cure not only for leukaemia, but cancer at large was announced this morning in London during GIL 2012: Europe. Steve Shor, the founder of the National Children's Leukemia Foundation, a leading non-profit organisation in the United States, unveiled a ground-breaking therapy his research teams in the United States and Israel have discovered.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in their extensive environmental monitoring (EM) programme for over 20 years
Edmonton researchers recommend that people over age 40 be screened for peripheral artery disease (PAD), which puts people at high risk for serious medical complications including heart disease, stroke, and possible lower limb amputation.
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarmad Sabour, MD 6870 W 52nd Ave Ste 207, Arvada, CO 80002-3953 Ph: (303) 487-0834 | Sarmad Sabour, MD 6870 W 52nd Ave Ste 207, Arvada, CO 80002-3953 Ph: (303) 487-0834 |
News Archive
A monumental discovery that provides the promise of a cure not only for leukaemia, but cancer at large was announced this morning in London during GIL 2012: Europe. Steve Shor, the founder of the National Children's Leukemia Foundation, a leading non-profit organisation in the United States, unveiled a ground-breaking therapy his research teams in the United States and Israel have discovered.
A study conducted by a team of researchers at the Harvard T.H. Chan School of Public Health has found that for women with an increased concentration of a common type of flame retardant in their urine, there is a decreased possibility of clinical pregnancy as well as live birth when compared to those with a lower concentration.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in their extensive environmental monitoring (EM) programme for over 20 years
Edmonton researchers recommend that people over age 40 be screened for peripheral artery disease (PAD), which puts people at high risk for serious medical complications including heart disease, stroke, and possible lower limb amputation.
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
› Verified 7 days ago
Dennis Victor Barcz, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7850 Vance Dr, Suite 225, Arvada, CO 80003 Phone: 303-431-8881 Fax: 303-431-8564 | |
Dale Kinzler, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7850 Vance Dr, Suite 225, Arvada, CO 80003 Phone: 303-431-8881 Fax: 303-431-8564 | |
Dr. David A Hartemink, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7850 Vance Dr, #225, Arvada, CO 80003 Phone: 303-431-8881 Fax: 303-431-8564 | |
David Wayne Vankooten, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7850 Vance Dr, Suite 225, Arvada, CO 80003 Phone: 303-431-8881 Fax: 303-431-8564 |